Most recently, Alentis Therapeutics raised $181.4M in its Later Stage VC (Series D) (Nov 2024).
- ·The complete investor list: 21 names
- ·Watch Alentis Therapeutics: the Monday email on marks, rounds and moves
Alentis Therapeutics round by round
2 roundsHow much has Alentis Therapeutics raised?
Alentis Therapeutics has raised $362 million in total; 2 of its rounds are on record. The largest on record was an $181 million Series D in Nov 2024.
Alentis Therapeutics investors
21 investors are on record for Alentis Therapeutics, including Bpifrance, RA Capital Management, High-Tech Gründerfonds and OrbiMed. By type, the record holds 5 venture capital firms and 1 family office. The Series D in Nov 2024 drew 12 investors.
21 investors have backed Alentis Therapeutics — start your target list with the firms already writing checks in drug discovery.
Frequently asked about Alentis Therapeutics
- How much has Alentis Therapeutics raised?
- Alentis Therapeutics has raised $362.5M in total across 2 recorded funding rounds.
- When was Alentis Therapeutics's last funding round?
- Alentis Therapeutics's most recent recorded round was Later Stage VC (Series D) in Nov 2024, raising $181.4M.